Principal Financial Group
PGNX

Principal Financial Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Principal Financial Group’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-666,732
Closed -$2.53M – 2405
2020
Q1 		$2.53M Sell
666,732
-28,123
-4% -$121K ﹤0.01% 1531
2019
Q4 		$3.54M Sell
694,855
-12,773
-2% -$67.6K ﹤0.01% 1617
2019
Q3 		$3.58M Buy
707,628
+4,436
+0.6% +$22.1K ﹤0.01% 1605
2019
Q2 		$4.34M Buy
703,192
+164
+0% +$791 ﹤0.01% 1575
2019
Q1 		$3.26M Sell
703,028
-6,693
-0.9% -$30.3K ﹤0.01% 1657
2018
Q4 		$2.98M Buy
709,721
+8,257
+1% +$42K ﹤0.01% 1645
2018
Q3 		$4.4M Buy
701,464
+105,765
+18% +$812K ﹤0.01% 1639
2018
Q2 		$4.79M Buy
595,699
+44,462
+8% +$339K ﹤0.01% 1608
2018
Q1 		$4.11M Buy
551,237
+2,945
+0.5% +$19.6K ﹤0.01% 1615
2017
Q4 		$3.26M Sell
548,292
-40,462
-7% -$246K ﹤0.01% 1678
2017
Q3 		$4.33M Sell
588,754
-6,095
-1% -$38.7K ﹤0.01% 1597
2017
Q2 		$4.04M Buy
594,849
+47,647
+9% +$352K ﹤0.01% 1616
2017
Q1 		$5.17M Buy
547,202
+534,759
+4,298% +$5.34M 0.01% 1521
2016
Q4 		$108K Buy
12,443
+417
+3% +$3.08K ﹤0.01% 2149
2016
Q3 		$76K Hold
12,026
– – ﹤0.01% 2123
2016
Q2 		$51K Hold
12,026
– – ﹤0.01% 2135
2016
Q1 		$52K Buy
12,026
+243
+2% +$1.08K ﹤0.01% 2124
2015
Q4 		$72K Hold
11,783
– – ﹤0.01% 2128
2015
Q3 		$67K Sell
11,783
-7,357
-38% -$56.5K ﹤0.01% 2119
2015
Q2 		$143K Sell
19,140
-487
-2% -$2.95K ﹤0.01% 2095
2015
Q1 		$118K Buy
19,627
+1,502
+8% +$9.45K ﹤0.01% 2087
2014
Q4 		$137K Buy
+18,125
New +$108K ﹤0.01% 2085
2014
Q2 		– Sell
-29,154
Closed -$119K – 2338
2014
Q1 		$119K Buy
+29,154
New +$149K ﹤0.01% 2215
2013
Q4 		– Sell
-23,268
Closed -$117K – 2324
2013
Q3 		$117K Buy
+23,268
New +$126K ﹤0.01% 2209

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Principal Financial Group's PGNX Position: Q2 2020 in Review

Principal Financial Group sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 666,732 shares — an estimated $2.53M sold.

Principal Financial Group first reported a position in PGNX in Q3 2013 and held it in 24 quarters. The position peaked at $5.17M in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Principal Financial Group reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Principal Financial Group sold 666,732 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $2.53M.
  • Principal Financial Group first reported a position in Progenics Pharmaceuticals Inc in Q3 2013 and held it in 24 quarters.
  • Principal Financial Group's Progenics Pharmaceuticals Inc position peaked at $5.17M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Principal Financial Group's 13F filing for Q2 2020, filed 5 Aug 2020.